Important sources of variability in clinical studies of neutralizing antibodies against interferon beta von Hurwitz, B.J

Volltext

Detection of Sequences Homologous to Human Retroviral DNA in Multiple Sclerosis by Gene Amplification von Greenberg, Steven J., Ehrlich, Garth D., Abbott, Mark A., Hurwitz, Barrie J., Waldmann, Thomas A., Poiesz, Bernard J.

Volltext

Longstanding Cardiac Perforation by a Permanent Endocardial Pacing Electrode von Hurwitz, B.J., Obel, I.W.P.

Volltext

Berg-adder Bite von Hurwitz, B.J. & Hull, P.R.

Volltext

Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer (MCRC): First-Line Analysis of Pooled Data From Randomized Controlled Trials (RCTS) von Kabbinavar, F.F., Hurwitz, H.I., Tebbutt, N.C., Giantonio, B.J., Guan, Z., Mitchell, L., Waterkamp, D., Tabernero, J.

Volltext

555P - Efficacy and Safety of Bevacizumab in Metastatic Colorectal Cancer (MCRC): First-Line Analysis of Pooled Data From Randomized Controlled Trials (RCTS) von Kabbinavar, F.F., Hurwitz, H.I., Tebbutt, N.C., Giantonio, B.J., Guan, Z., Mitchell, L., Waterkamp, D., Tabernero, J.

Volltext

Results from a Phase 2 Study of Ruxolitinib or Placebo with Capecitabine as Second-Line Therapy in Patients with Metastatic Pancreatic Cancer: The Recap Trial von Hurwitz, H., Uppal, N., Wagner, S.A., Bendell, J., Thaddeus, B.J., Wade, S., Nemunaitis, J., Stella, P., Pipas, J.M., Wainberg, Z., Manges, R., Garrett, W., Hunter, D., Clark, J., Leopold, L., Levy, R., Sandor, V.

Volltext

465 DISCUSSION A Phase 1 dose escalating study of ACE-041, a novel inhibitor of ALK-1 mediated angiogenesis, in patients with advanced solid tumors von Sharma, S, Bendell, J.C, Hurwitz, H, Condon, C.H, Thornell, B.J, Slatcher, P.L, Borgstein, N.G, Sherman, M.L, Gordon, M.S

Volltext

367 A first-in-human Phase 1 study of anti-CD105 antibody therapy with TRC105 in patients with advanced solid tumors von Rosen, L, Gordon, M.S, Hurwitz, H.I, Wong, M.K, Goldman, J, Adams, B.J, Alvarez, D, Seon, B.K, Theuer, C.P, Leigh, B.R

Volltext

Abnormalities in muscle function during gait in relation to the level of lumbar disc herniation von MORAG, E, HURWITZ, D. E, ANDRIACCHI, T. P, HICKEY, M, ANDERSSON, G. B. J

Volltext

400 POSTER Early evidence of tolerability and clinical activity from a phase 1 study of TRC105 (anti-CD105 antibody) in patients with advanced refractory cancer von Rosen, L.S, Gordon, M.S, Hurwitz, H.I, Mendelson, D.S, Kleinzweig, D, Adams, B.J, Theuer, C.P

Volltext